Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Access

Set Alert for Market Access

Could CMS Changes To Bundled Pay Models Stifle Medtechs' Value-Based Pay Plans?

The US Center for Medicare and Medicaid Services proposed downsizing its CJR joint replacement value-based payment model and outright canceling its cardiac procedure bundled payment model. Will the move discourage companies like Zimmer Biomet, Johnson & Johnson, and Medtronic, which have already invested in programs based on the value-based models?

Reimbursement Market Access United States
Advertisement

Latest From Market Access

India Strikes Pricing Blow To Knees After Stent Cuts

Six months after imposing stiff price controls on cardiac stents, India’s government slashed costs of knee implants by nearly 70%, saying the action was necessary to end “unethical profiteering.”

Orthopedics India

Patrick Conway Departs CMS As It Diverges From His Vision

Conway, a champion of the US agency's move into value-based care, will take the helm at Blue Cross/Blue Shield of North Carolina.

Policy Medical Device

UK Viewpoint: AHSNs, AAR And Accelerators – Market Access & Innovation Update

Dr Charlie Davie, managing director of UCLPartners, a London-based Academic Health Science Partnership and one of the 15 UK Academic Health Science Networks, updates Medtech Insight on key changes in NHS market access policy this summer.

United Kingdom Market Access

Medicare Proposal To Cover Outpatient Knee, Hip Procedures Raises Patient Selection, Bundling Questions

Improvements in technology surrounding knee and hip replacements means a shorter recovery time for patients, but a recent US CMS proposal to take the procedures off the "inpatient procedure only" list means surgeons will have to carefully choose Medicare patients that are appropriate for the outpatient setting, and payment bundles could be affected.

Reimbursement Orthopedics

No Easy Task But Insulet Determined To Fly Solo In Europe

After eight years together, Insulet will be splitting from its exclusive European distributor Ypsomed and take full responsibility for the distribution, sales, marketing, training and support activities of its Omnipod insulin management system in that region. Insulet's president and chief operating officer, Shacey Petrovic told Medtech Insight how the Massachusetts-based company will embark on this next solo chapter.

Diabetic Care Market Access

Turkey Homes In On Imaging Sector To Boost Local Medtech Production

In a bid to increase local products of medical equipment and reduce costs of importing expensive devices, Turkey has introduced financial incentives to attract multinationals to set up manufacturing facilities in the country. One priority area of this initiative will be medical imaging technologies.

Turkey Policy
See All
UsernamePublicRestriction

Register